EUVIMEDEUVIMED entdecken
Open Access

Holmium laser enucleation of prostate (HoLEP) in nonagenarians and octogenarians

Mohamed Elsaqa, Yu Zhang, Marawan M El Tayeb

Canadian Urological Association Journal · 11.07.2023 · 17 (9)

DOI: 10.5489/cuaj.8211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Urological Association Journal, online erschienen am 11.07.2023. Verfasst von Mohamed Elsaqa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Baylor Scott & White Health, CTX, Temple, TX, United States. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Holmium laser enucleation of the prostate (HoLEP) is a well-established technique for management of benign prostatic hyperplasia (BPH). With the growing aging population, a considerable percentage of octogenarians (80–90 years old) and nonagenarians (>90 years old) require surgical management for BPH. We aimed to assess the outcomes of HoLEP in those age groups.

Methods

We reviewed a maintained database for HoLEP patients in a tertiary center. Patients were assigned to two groups: above (group A) and below (group B) 80 years old. Perioperative outcome and postoperative followup data were compared between both groups.

Results

The study included 1090 patients, 201 and 889 in groups A and B, respectively. Median age was 83 and 70 years in groups A and B, respectively. Group A showed longer operative time, longer catheterization time, and higher 30-day emergency room visits and readmission rates. Hemoglobin drop was comparable, although associated with higher rate of blood transfusion in group A. Overall, 30-day postoperative complications were higher in group A (20.8% vs, 9.3%, p= 0.008), although the majority of complications in both groups were grade I and II. The rate of complications over Clavien-Dindo grade II were statistically comparable (3.4% vs. 1.79%, p= 0.133). Followup at six weeks, three months, and one year showed comparable functional outcomes in both groups.

Conclusions

HoLEP is a safe and effective option in the geriatric population of octogenarians and even nonagenarians. HoLEP is associated with higher overall complication rate in older age groups; however, most complications were minor.

Autor:innen und Institutionen

  • Baylor Scott & White Health, CTX, Temple, TX, United States.
  • Alexandria University Faculty of Medicine, Alexandria, Egypt.

Zitieren

APA

Elsaqa, M., Zhang, Y., & El Tayeb, M. M. (2023). Holmium laser enucleation of prostate (HoLEP) in nonagenarians and octogenarians. Canadian Urological Association Journal, 17(9). https://doi.org/10.5489/cuaj.8211

Vancouver

Elsaqa M, Zhang Y, El Tayeb MM. Holmium laser enucleation of prostate (HoLEP) in nonagenarians and octogenarians. Canadian Urological Association Journal. 2023;17(9). doi:10.5489/cuaj.8211

BibTeX
@article{Elsaqa2023,
  author = {Elsaqa, Mohamed and Zhang, Yu and El Tayeb, Marawan M},
  title = {Holmium laser enucleation of prostate (HoLEP) in nonagenarians and octogenarians},
  journal = {Canadian Urological Association Journal},
  year = {2023},
  volume = {17},
  number = {9},
  doi = {10.5489/cuaj.8211}
}
Kostenlos starten →